BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

578 related articles for article (PubMed ID: 21607949)

  • 1. Human papillomavirus status in young patients with head and neck squamous cell carcinoma.
    van Monsjou HS; van Velthuysen ML; van den Brekel MW; Jordanova ES; Melief CJ; Balm AJ
    Int J Cancer; 2012 Apr; 130(8):1806-12. PubMed ID: 21607949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus E7 serology and association with p16 immunohistochemistry in squamous cell carcinoma of the head and neck.
    Khanal S; Joh J; Kwon AM; Zahin M; Perez CA; Dunlap NE; Silverman CL; Tennant PA; Potts KL; Kloecker GH; Bumpous JM; Ghim SJ; Jenson AB; Redman RA
    Exp Mol Pathol; 2015 Oct; 99(2):335-40. PubMed ID: 26116154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-risk human papillomavirus in oral squamous cell carcinoma of young patients.
    Kaminagakura E; Villa LL; Andreoli MA; Sobrinho JS; Vartanian JG; Soares FA; Nishimoto IN; Rocha R; Kowalski LP
    Int J Cancer; 2012 Apr; 130(8):1726-32. PubMed ID: 21618514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A subset of head and neck squamous cell carcinomas exhibits integration of HPV 16/18 DNA and overexpression of p16INK4A and p53 in the absence of mutations in p53 exons 5-8.
    Hafkamp HC; Speel EJ; Haesevoets A; Bot FJ; Dinjens WN; Ramaekers FC; Hopman AH; Manni JJ
    Int J Cancer; 2003 Nov; 107(3):394-400. PubMed ID: 14506739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterization of p16-immunopositive but HPV DNA-negative oropharyngeal carcinomas.
    Rietbergen MM; Snijders PJ; Beekzada D; Braakhuis BJ; Brink A; Heideman DA; Hesselink AT; Witte BI; Bloemena E; Baatenburg-De Jong RJ; Leemans CR; Brakenhoff RH
    Int J Cancer; 2014 May; 134(10):2366-72. PubMed ID: 24249631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers of HPV in head and neck squamous cell carcinoma.
    Liang C; Marsit CJ; McClean MD; Nelson HH; Christensen BC; Haddad RI; Clark JR; Wein RO; Grillone GA; Houseman EA; Halec G; Waterboer T; Pawlita M; Krane JF; Kelsey KT
    Cancer Res; 2012 Oct; 72(19):5004-13. PubMed ID: 22991304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Automated Extraction of Formalin-Fixed, Paraffin-Embedded Tissue for High-Risk Human Papillomavirus Testing of Head and Neck Squamous Cell Carcinomas Using the Roche Cobas 4800 System.
    Kerr DA; Sweeney B; Arpin RN; Ring M; Pitman MB; Wilbur DC; Faquin WC
    Arch Pathol Lab Med; 2016 Aug; 140(8):844-8. PubMed ID: 27031775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of p16(INK4a) /Ki67 immunocytology and HPV polymerase chain reaction for the noninvasive analysis of HPV involvement in head and neck cancer.
    Linxweiler M; Bochen F; Wemmert S; Lerner C; Hasenfus A; Bohle RM; Al-Kadah B; Takacs ZF; Smola S; Schick B
    Cancer Cytopathol; 2015 Apr; 123(4):219-29. PubMed ID: 25557267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of cell cycle-associated proteins p16, pRB, cyclin D1 and p53 in resected oropharyngeal carcinoma.
    Plath M; Broglie MA; Förbs D; Stoeckli SJ; Jochum W
    J Otolaryngol Head Neck Surg; 2018 Sep; 47(1):53. PubMed ID: 30189895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of human papillomavirus-16 in fine-needle aspirates to determine tumor origin in patients with metastatic squamous cell carcinoma of the head and neck.
    Begum S; Gillison ML; Nicol TL; Westra WH
    Clin Cancer Res; 2007 Feb; 13(4):1186-91. PubMed ID: 17317828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive evaluation of human papillomavirus positive status and p16INK4a overexpression as a prognostic biomarker in head and neck squamous cell carcinoma.
    Deng Z; Hasegawa M; Aoki K; Matayoshi S; Kiyuna A; Yamashita Y; Uehara T; Agena S; Maeda H; Xie M; Suzuki M
    Int J Oncol; 2014 Jul; 45(1):67-76. PubMed ID: 24820457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-risk HPV genotypes and P16INK4a expression in a cohort of head and neck squamous cell carcinoma patients in Singapore.
    Tan LS; Fredrik P; Ker L; Yu FG; Wang Y; Goh BC; Loh KS; Lim CM
    Oncotarget; 2016 Dec; 7(52):86730-86739. PubMed ID: 27893418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the antileukoprotease SLPI in smoking-induced human papillomavirus-independent head and neck squamous cell carcinomas.
    Quabius ES; Möller P; Haag J; Pfannenschmidt S; Hedderich J; Görögh T; Röcken C; Hoffmann M
    Int J Cancer; 2014 Mar; 134(6):1323-34. PubMed ID: 23996702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-risk HPV DNA status and p16 (INK4a) expression as prognostic markers in patients with squamous cell cancer of oral cavity and oropharynx.
    Śnietura M; Jaworska M; Pigłowski W; Goraj-Zając A; Woźniak G; Lange D
    Pol J Pathol; 2010; 61(3):133-9. PubMed ID: 21225495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P16(INK4A) immunostaining is a strong indicator for high-risk-HPV-associated oropharyngeal carcinomas and dysplasias, but is unreliable to predict low-risk-HPV-infection in head and neck papillomas and laryngeal dysplasias.
    Mooren JJ; Gültekin SE; Straetmans JM; Haesevoets A; Peutz-Kootstra CJ; Huebbers CU; Dienes HP; Wieland U; Ramaekers FC; Kremer B; Speel EJ; Klussmann JP
    Int J Cancer; 2014 May; 134(9):2108-17. PubMed ID: 24127203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined P16 and human papillomavirus testing predicts head and neck cancer survival.
    Salazar CR; Anayannis N; Smith RV; Wang Y; Haigentz M; Garg M; Schiff BA; Kawachi N; Elman J; Belbin TJ; Prystowsky MB; Burk RD; Schlecht NF
    Int J Cancer; 2014 Nov; 135(10):2404-12. PubMed ID: 24706381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral RNA patterns and high viral load reliably define oropharynx carcinomas with active HPV16 involvement.
    Holzinger D; Schmitt M; Dyckhoff G; Benner A; Pawlita M; Bosch FX
    Cancer Res; 2012 Oct; 72(19):4993-5003. PubMed ID: 22991302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pilot study to compare the detection of HPV-16 biomarkers in salivary oral rinses with tumour p16(INK4a) expression in head and neck squamous cell carcinoma patients.
    Chai RC; Lim Y; Frazer IH; Wan Y; Perry C; Jones L; Lambie D; Punyadeera C
    BMC Cancer; 2016 Mar; 16():178. PubMed ID: 26940728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus status and p16(INK4A) expression in patients with mucosal squamous cell carcinoma of the head and neck in Queensland, Australia.
    Antonsson A; Neale RE; Boros S; Lampe G; Coman WB; Pryor DI; Porceddu SV; Whiteman DC
    Cancer Epidemiol; 2015 Apr; 39(2):174-81. PubMed ID: 25677091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The frequency of high-risk human papillomavirus types, HPV16 lineages, and their relationship with p16
    Pakdel F; Farhadi A; Pakdel T; Andishe-Tadbir A; Alavi P; Behzad-Behbahani A; Ashraf MJ
    Braz J Microbiol; 2021 Mar; 52(1):195-206. PubMed ID: 33169334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.